Why Tablet Size Matters for Patient Compliance

A medicine only works if the patient actually takes it. Yet one of the most overlooked barriers to adherence is simple: the tablet is too big to swallow comfortably. Tablet size is not a cosmetic detail — it directly affects whether patients stay on their therapy.

The Swallowing Problem

Difficulty swallowing tablets (dysphagia) is common, especially among elderly patients and those on multiple daily medicines. Large tablets cause discomfort, anxiety, and in many cases patients splitting, crushing, or skipping doses altogether — each of which can compromise the intended dose and outcome. For chronic conditions like diabetes and hypertension, where adherence is everything, tablet size becomes a genuine clinical concern.

Why Tablets Get Large

A tablet's size is driven largely by its excipient load — the inactive ingredients added to make the powder flow and compress. Traditional manufacturing often requires substantial excipient content to achieve acceptable tableting, inflating the final tablet size well beyond the active dose.

How DC Granules Reduce Tablet Size

Directly Compressible Granules are engineered for excellent flow and compressibility with a minimal excipient load. Higher active-ingredient content and lower excipient content mean the same dose can be delivered in a physically smaller tablet. For example, a YSK Metformin 1000 mg SR tablet weighs around 1050 mg total, compared with a leading competitor brand at 1402 mg — roughly 25% smaller for the same dose.

Smaller Tablets, Better Outcomes

A smaller, easier-to-swallow tablet is more than a comfort feature. It improves adherence, reduces the temptation to split or skip doses, and supports better therapeutic outcomes — particularly for elderly and polypharmacy patients. It's a small change with a meaningful impact on real-world effectiveness.

Building Patient-Friendly Tablets

Achieving smaller tablets starts at the granule. By choosing DC Granule technology with a low excipient profile, formulators can design products that patients find easier to take. At YSK Laboratories, our proprietary direct-compression technology is specifically engineered to minimize excipient load and tablet size. Explore our DC Granules range or get in touch to develop a more patient-friendly formulation.

Hyperlinks to apply:

• "DC Granules range" → https://www.ysklabs.com/granules

• "get in touch" → https://www.ysklabs.com/contact-8